Leading Off: Pharmaceuticals in the Dry Eye Disease Pipeline - Top-Institutions - MDSpire

Leading Off: Pharmaceuticals in the Dry Eye Disease Pipeline

New innovations targeting dry eye disease (DED) are in the pipeline to enable us to tailor our treatments to the specific underlying causes of DED.

  • By

  • SHANE R. KANNARR, OD

  • Christoper J. Jacquinot, OD

  • Ryan A. Cedeno, OD

  • July 1, 2025

  • 1 min

Share

Top Institutions in Optometry

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease

  • #2

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease

  • #3

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease

  • #4

    University of California, San Francisco (UCSF) Department of Ophthalmology
    University of California, San Francisco (UCSF) Department of Ophthalmology

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease

  • #5

    Duke University Eye Center
    Duke University Eye Center

    Durham, NC

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease

Original Source(s)

Leading Off: Pharmaceuticals in the Dry Eye Disease Pipeline

  • by SHANE R. KANNARR, OD, Christoper J. Jacquinot, OD, Ryan A. Cedeno, OD

  • July 1, 2025

Related Content

Japan Debuts Novel Dry Eye Therapy

Senju Pharmaceutical launches the first TRPV1 antagonist for dry eye in Japan

  • April 30, 2026

  • 3 min
What's New in DED in 2026?

"It's all about finding what's wrong with your patient

  • January 1, 2026

  • 1 min
Why I Built a Beauty Brand as an Ophthalmologist

Bridging the divide between eye health and cosmetics represents the natural evolution of compassionate, patient-centered care